Literature DB >> 29747306

[Updates of Chinese Society of Clinical Oncology (CSCO) guideline for breast cancer in 2018].

X Huang, Y M Yin.   

Abstract

Entities:  

Year:  2018        PMID： 29747306     DOI： 10.3760/cma.j.issn.0376-2491.2018.16.005

Source DB:  PubMed          Journal:  Zhonghua Yi Xue Za Zhi        ISSN： 0376-2491


× No keyword cloud information.
  7 in total

1.  The Clinical Observation and Mechanism of Acupuncture on Cancer-Related Fatigue of Breast Cancer Based on "Gut-Brain Axis": Study Protocol for a Randomized Controlled Trial.

Authors:  Zhuan Lv; Yi-Ming Gu; Rui-Dong Liu; Kai-Qi Su; Xiao-Di Ruan; Yi-Niu Chang; Jing Gao; Rui-Qing Li; Lu Fang; Xiao-Dong Feng
Journal:  Dis Markers       Date:  2022-05-07       Impact factor: 3.464

2.  Evaluation of the body mass index in breast cancer prognosis in a cohort of small-stature overweight patients: multi-center study in China.

Authors:  Xin Tan; Danju Huang; Fan Zhang; Yingzhu Zhao; Mingjian Tan; Hongwan Li; Hengyu Zhang; Ke Wang; Huimeng Li; Dequan Liu; Rong Guo; Shicong Tang
Journal:  Gland Surg       Date:  2021-01

3.  Relationship between red cell distribution width and prognosis in patients with breast cancer after operation: a retrospective cohort study.

Authors:  Deshun Yao; Zhiwu Wang; Haifeng Cai; Ying Li; Baosheng Li
Journal:  Biosci Rep       Date:  2019-07-12       Impact factor: 3.840

4.  Comparison of circulating tumor cell (CTC) detection rates with epithelial cell adhesion molecule (EpCAM) and cell surface vimentin (CSV) antibodies in different solid tumors: a retrospective study.

Authors:  Yang Gao; Wan-Hung Fan; Zhengbo Song; Haizhou Lou; Xixong Kang
Journal:  PeerJ       Date:  2021-03-02       Impact factor: 2.984

5.  Evaluation of circulating tumor cells as a prognostic biomarker for early recurrence in stage II-III breast cancer patients using CytoSorter® system: a retrospective study.

Authors:  Lidan Jin; Wan-Hung Fan; Yi Luan; Meiqiong Wu; Wenhe Zhao
Journal:  PeerJ       Date:  2021-04-29       Impact factor: 2.984

6.  A comprehensive comparison of circulating tumor cells and breast imaging modalities as screening tools for breast cancer in Chinese women.

Authors:  Xuan Shao; Xiaoyan Jin; Zhigang Chen; Zhigang Zhang; Wuzhen Chen; Jingxin Jiang; Zhen Wang; Ying Cui; Wan-Hung Fan; Ke Wang; Xiuyan Yu; Jian Huang
Journal:  Front Oncol       Date:  2022-08-01       Impact factor: 5.738

7.  Individualized lncRNA differential expression profile reveals heterogeneity of breast cancer.

Authors:  Zhangxiang Zhao; YingYing Guo; Yaoyao Liu; Lichun Sun; Bo Chen; Chengyu Wang; Tingting Chen; Yuquan Wang; Yawei Li; Qi Dong; Liqiang Ai; Ran Wang; Yunyan Gu; Xia Li
Journal:  Oncogene       Date:  2021-06-15       Impact factor: 9.867
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.